A detailed history of Smartleaf Asset Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 158 shares of CTLT stock, worth $9,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Previous 2,955 94.65%
Holding current value
$9,573
Previous $132 Million 93.27%
% of portfolio
0.0%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $149,863 - $159,484
-2,797 Reduced 94.65%
158 $8.91 Million
Q1 2024

May 02, 2024

BUY
$42.56 - $59.82 $3,915 - $5,503
92 Added 3.21%
2,955 $132 Million
Q4 2023

Feb 12, 2024

BUY
$32.18 - $46.57 $92,131 - $133,329
2,863 New
2,863 $130 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.